Mayzent is a medicine used to treat adults with an advanced form of multiple sclerosis (MS) known as secondary progressive MS. It is used in patients with active disease, which means that patients still have relapses or signs of inflammation can be seen in scans. Mayzent contains the active substance siponimod.
Therapeutic Indication
### Therapeutic indication Mayzent is indicated for the treatment of adult patients with secondary progressive multiple sclerosis (SPMS) with active disease evidenced by relapses or imaging features of inflammatory activity.
Therapeutic Area (MeSH)
ATC Code
L04
ATC Item
免疫抑制剂
Pharmacotherapeutic Group
Selective immunosuppressants
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| siponimod fumaric acid | N/A | Siponimod Fumaric Acid |
| Siponimod fumaric acid | N/A | Siponimod Fumaric Acid |
EMA Name
Mayzent
Medicine Name
Mayzent
Aliases
N/A
